Efficacy And Safety Of Antioxidant Treatment With α-lipoic Acid Over 4 Years In Diabetic Polyneuropathy: The NATHAN 1 Trial

Effect None
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 460
Sex Both Genders
Age Range 45-64
Body Types Obese, Overweight
Notes for this study:
4 years usage of 600mg ALA racemic mixture daily was unable to offer protection from diabetes, and was not significantly more effective than placebo.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.